Otolith Labs, maker of a headband wearable that aims to treat chronic vertigo, raised $20 million in a Series A round led by Morningside Ventures.
The company announced last year the device had received FDA Breakthrough Device Designation alongside the close of a $3.3 million seed round. The Breakthrough Devices Program isn’t marketing approval from the FDA, but it aims to accelerate review of...